During the past decade, Nuvisan GmbH conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 1 clinical trials were completed, i.e. on average, 2.9% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 1 clinical trials were completed. i.e. 5.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nuvisan GmbH" #1 sponsor was "Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany" with 10 trials, followed by "Merck KGaA, Darmstadt, Germany" with 7 trials sponsored, "Bayer" with 4 trials sponsored, "Aptarion Biotech AG" with 2 trials sponsored and "BioVersys SAS" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nuvisan GmbH" #1 collaborator was "FGK Clinical Research GmbH" with 2 trials as a collaborator, "Nuvisan GmbH" with 2 trials as a collaborator, "ADIR, a Servier Group company" with 1 trials as a collaborator, "Charles River Biopharmaceutical Services GmbH" with 1 trials as a collaborator and "EUROCALIN Consortium" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Nuvisan GmbH" are "Healthy" (22 trials), "Healthy Volunteers" (3 trials), "Contraception" (2 trials), "Clinical Pharmacology" (1 trials) and "Diabetic Retinopathy" (1 trials). Many other conditions were trialed in "Nuvisan GmbH" in a lesser frequency.

Most popular intervention types in "Nuvisan GmbH" are "Drug" (35 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Evobrutinib" (4 trials), "Midazolam" (4 trials), "Tepotinib" (3 trials) and "BV100" (2 trials). Other intervention names were less common.

The vast majority of trials in "Nuvisan GmbH" are 23 trials for "All" genders, 11 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Nuvisan GmbH". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in Nuvisan GmbH, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Nuvisan GmbH, 35 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".